Parekh, Vishwas <br/><br/>
NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib.  [electronic resource] 

 -  Journal of cutaneous pathology  Mar 2019 
 - 190-194 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1600-0560 
<br/><br/><label>Standard No.: </label>10.1111/cup.13401  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged, 80 and over<br/>Antineoplastic Agents--adverse effects<br/>Female<br/>GTP Phosphohydrolases--genetics<br/>Humans<br/>Male<br/>Melanoma--drug therapy<br/>Membrane Proteins--genetics<br/>Mutation<br/>Neoplasms, Second Primary--chemically induced<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Retrospective Studies<br/>Skin Neoplasms--chemically induced<br/>Vemurafenib--adverse effects<br/>Melanoma, Cutaneous Malignant